Consensus Organigram Global Inc.

Stocks

OGI

CA68617J1003

Healthcare Facilities & Services

Market Closed - Toronto S.E. 01:29:56 29/08/2026 am IST			5-day change	1st Jan Change
1.680 ^CAD	0.00%		-1.75%	-27.27%

20/08	Organigram Global Inc. Announces Management Changes	CI
11/08	Organigram Global Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026	CI

Evolution of the Average Target: Organigram Global Inc.

Evolution of the Target Price: Organigram Global Inc.

Changes in Analyst Recommendations: Organigram Global Inc.

f25ffbc48a43825.jqcn-QQPXISpwPY8GBCWnLeTyrk3ld_uHR8L2ET_Ofc.7e14nTE7Gv7dgcZpdEDOw5rU-vgEopiJZElkrwKMaKTH5WauSWEd7vOauw~a051a3625e987c21fbac5f88bf8aea66

Analysts' recommendations: Organigram Global Inc.

23/03	Organigram Says Proxy Firm ISS Recommends Approval of Sanity Group Acquisition	MT
23/03	Organigram Brief: Announced Independent Proxy Advisory Firm ISS Recommends OGI Shareholders Vote FOR Acquisition of Sanity Group GmbH	MT
21/25/21	Organigram Brief: Announcing Update to CEO Succession Plan	MT
15/24/15	Alliance Global Upgrades OrganiGram Holdings to Buy From Neutral	MT
17/23/17	Organigram Holdings Maintained at Buy at Stifel GMP Following Q2 Results; Price Target Raised to C$4.00	MT
13/23/13	Organigram Holdings Maintained at Buy at Stifel GMP After Mixed Fiscal Q2 Results; Price Target Lowered to C$1.25	MT
13/23/13	Organigram Holdings Raised to Buy at Stifel GMP Following Improved FQ1 Results; Price Target Kept at C$1.50	MT
29/22/29	Organigram Holdings Maintained at Hold at Stifel GMP Following FQ4 Results; Price Target Kept at C$1.50	MT
15/22/15	Organigram Holdings Hold Rating Maintained by Stifel GMP Following Fiscal Third-Quarter Results	MT
13/22/13	Organigram Holdings Shares Rise 4%, Upgraded to Outperform at ATB Capital	MT
12/22/12	Canaccord Genuity Upgrades OrganiGram Holdings to Speculative Buy from Hold, Adjusts Price Target to CA$3.25 from CA$3	MT
12/22/12	Organigram Holdings Price Target Raised to $3 at ATB Capital	MT
15/21/15	OrganiGram : Stifel Nicolaus Adjusts OrganiGram Holdings PT to C$3.75 From C$4, Maintains Hold Rating	MT
14/21/14	OrganiGram : CIBC Adjusts OrganiGram Holdings PT to C$4 From C$3.75, Maintains Neutral Rating	MT
11/21/11	OrganiGram : CIBC Adjusts OrganiGram Holdings PT to C$3.75 From C$3.25, Maintains Neutral Rating	MT
11/21/11	OrganiGram : CIBC Upgrades OrganiGram Holdings to Neutral from Underperform, Keeps C$3.25 Price Target	MT
15/21/15	OrganiGram : Stifel Nicolaus Adjusts OrganiGram Holdings PT to C$4 From C$6, Maintains Hold Rating	MT
14/21/14	OrganiGram : Raymond James Adjusts OrganiGram Holdings PT to C$5 From C$6, Maintains Outperform Rating	MT
14/21/14	Organigram : Declines 7% As CIBC Downgrades Stock After Weak Q2 Results	MT
14/21/14	OrganiGram : CIBC Downgrades OrganiGram Holdings to Underperform from Neutral, Adjusts PT to C$3.25 from C$5	MT
08/21/08	OrganiGram : BMO Capital Upgrades OrganiGram Holdings to Market Perform from Underperform, Sets C$4 Price Target	MT
12/21/12	OrganiGram : Raymond James Adjusts OrganiGram Holdings PT to C$6 From C$3, Maintains Outperform Rating	MT
11/21/11	OrganiGram : Alliance Global Partners Adjusts OrganiGram Holdings PT to C$4 From C$2.25, Maintains Neutral Rating	MT
10/21/10	OrganiGram : BMO Capital Downgrades OrganiGram Holdings to Underperform From Market Perform	MT
13/21/13	OrganiGram : Raymond James Upgrades OrganiGram Holdings to Outperform From Market Perform; Price Target is C$3	MT

More recommendations

Medical Farming

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' Target price divergence	Objective/dr gap
ORGANIGRAM GLOBAL INC.		+85.71%
VILLAGE FARMS INTERNATIONAL, INC.		+103.96%
CANNARA BIOTECH INC.		+68.75%
ASCEND WELLNESS HOLDINGS, INC.		+474.4%
VEXT SCIENCE, INC.	-	+239.29%
Average		+194.42%
Weighted average by Cap.		+141.87%